Atossa Therapeutics, Inc.
ATOS
Revenue
0.00
0.000.00%
3 Months ChangeAssets
85.86M
▼-5.23M▼-5.74%
3 Months ChangeLiabilities
5.70M
▲368.00k▲6.91%
3 Months ChangeFree Cash Flow
-4.70M
▲2.32M▲33.01%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-12
Form 10-Q
ID: 0000950170-24-095102
2024-08-12
Form 8-K
ID: 0000950170-24-095097
2024-07-02
Form 8-K
ID: 0000950170-24-080497
2024-05-13
Form 10-Q
ID: 0000950170-24-058244
2024-05-13
Form 8-K
ID: 0000950170-24-058242
2024-04-01
Form 8-K
ID: 0000950170-24-039286
2024-03-18
Form 8-K
ID: 0000950170-24-032535
2024-03-12
Form 8-K
ID: 0000950170-24-029671
2023-11-13
Form 10-Q
ID: 0001437749-23-031424
2023-11-13
Form 8-K
ID: 0001437749-23-031420